Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Accumulating evidence demonstrates an association of type 2 diabetes and its microvascular complications with increased fracture risk. In this study, we aimed to evaluate the relationships between serum concentrations of bone turnover markers and the presence and/or severity of diabetic retinopathy (DR) among type 2 diabetic patients.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>A total of 285 type 2 diabetic patients comprising 168 patients without DR and 117 patients with DR were enrolled in the cross‐sectional study. In the latter group, patients were further divided into patients of mild and severe DR stages. The biochemical parameters and bone turnover markers were determined in all participants.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>This paper found that serum levels of procollagen type 1 N‐terminal propeptide (P1NP), a bone formation marker, and a bone resorption marker serum β‐crossLaps (β‐CTX) were decreased in diabetic patients with DR than those without DR, with differences remained significant (<i>P </i> < 0.05) in multivariate linear regression models after adjustments for multiple confounding factors. Osteocalcin and β‐CTX levels were further reduced along with the severity of DR among participants with DR. Moreover, multivariate logistic regression analysis revealed that lower serum levels of P1NP and β‐CTX were associated with higher odds for the presence of DR while β‐CTX was with the severity of DR. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>Our results suggested the development of DR might be involved in the progression in T2DM induced deficits in bone formation and resorption or vice versa. Follow‐up study and further research are necessary to validate the associations and elucidate the underlying mechanisms.</p></section>

Vitamin D receptor and estrogen receptor gene polymorphisms in men with type 2 diabetes: Effects on Bone Metabolism

Association of vitamin D receptor gene polymorphism with the occurrence of low bone density, osteopenia, and osteoporosis in patients with type 2 diabetes

Estrogen receptor α and vitamin D receptor gene polymorphisms and bone mineral density: association study of healthy pre- and postmenopausal Chinese women

Association of Estrogen Receptor α and Vitamin D Receptor Gene Polymorphisms with Bone Mineral Density in Chinese Males

Vitamin D receptor gene polymorphism and serum vitamin D level as risk factors for acquiring Type II diabetes mellitus

Association of rs4516035 Polymorphism with Osteoporosis in the Southeastern Iranian Population: A Case-Control Study

Relationship of vitamin D receptor gene polymorphisms with bone turnover markers and 1, 25-dihydroxy vitamin D3 in elderly men

Interaction Effects Between Estrogen Receptor Α Gene, Vitamin D Receptor Gene, Age, and Sex on Bone Mineral Density in Chinese

Cdx-2 Polymorphism in Vitamin D Receptor Gene Was Associated with Serum 25-Hydroxyvitamin D Levels, Bone Mineral Density and Fracture in Middle-Aged and Elderly Chinese Women

Evaluation of Association Studies and an Updated Meta-Analysis of VDR Polymorphisms in Osteoporotic Fracture Risk

Association of Vitamin D Receptor (FokI and BsmI) Gene Polymorphism with Bone Mineral Density and Their Effect on 25-Hydroxyvitamin D Level in North Indian Postmenopausal Women with Osteoporosis

Associations between the VDR Gene rs731236 (TaqI) Polymorphism and Bone Mineral Density in Postmenopausal Women from the RAC-OST-POL

Determinants of Vitamin D deficiency among type 2 diabetes mellitus patients: A retrospective study

Vitamin D Status, Vitamin D Receptor Polymorphisms, and Risk of Type 2 Diabetes: A Prospective Cohort Study

Bone Fracture Incidence in Postmenopausal Women: Results of a 10 Year Follow Up in a RAC-OST-POL Study of rs1544410, rs7975232 and rs731236 Polymorphisms

Vitamin D is Glucoprotective in Aging Males but Not Females

Association between bone turnover markers, bone mineral density, and serum osteoglycine in middle-aged men with Type 2 Diabetes mellitus

Diabetes and osteoporosis: a two-sample mendelian randomization study

Association of Estrogen Receptor Alpha Gene Polymorphisms with Bone Mineral Density: a Meta-Analysis.

Vitamin D Receptor Gene Polymorphism and Vitamin D Status in Population of Patients with Cardiovascular Disease—A Preliminary Study

Low serum levels of bone turnover markers are associated with the presence and severity of diabetic retinopathy in patients with type 2 diabetes mellitus